While new care delivery models have provided better support for patients, there are still many patients who still face challenges with the complexity of treatment, explained Daniel J. Klein, president and chief executive officer of the Patient Access Network (PAN) Foundation.
While new care delivery models have provided better support for patients, there are still many patients who still face challenges with the complexity of treatment, explained Daniel J. Klein, president and chief executive officer of the Patient Access Network (PAN) Foundation.
PAN's largest role is to eliminate financial barriers that prevent patients from starting treatment and make it difficult for them to complete treatment.
"By eliminating the deductibles and the copays for patients who are using specialty medications in particular, PAN, I think, has really encouraged patients to stay on therapy and hopefully be more sucessful with their therapies," Mr Klein said.
He also outlined the new PAN Challenge, launched in coordination with The American Journal of Managed Care. PAN is seeking papers on sustainable ways to balance financial issues for patients on specialty medications.
"I think that what we're hoping is the challenge will get some of the best and the brightest thinkers from academia and from healthcare systems to put forward their thoughts on how to address the challenges around cost-sharing and being able to sustain the kinds of new and innovative treatments that specialty medications represent," he said.
Learn more about the PAN Challenge: www.panfoundation.org/challenge/
Bridging the Gaps: New Strategies for Preventing Cardiovascular Disease
July 31st 2025During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discussed innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, and collaborative care to improve patient outcomes.
Read More
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More
The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities
July 30th 2025Key legal, ethical, and compliance considerations for managed care professionals navigating the evolving landscape of psychedelic-assisted therapy include regulatory risks, data privacy challenges, reimbursement limitations, and the need for culturally informed care models.
Read More